• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatment.

作者信息

Odeberg J, Yun Z, Sönnerborg A, Weiland O, Lundeberg J

机构信息

Department of Biochemistry and Biotechnology, Royal Institute of Technology, Stockholm, Sweden.

出版信息

J Med Virol. 1998 Sep;56(1):33-8. doi: 10.1002/(sici)1096-9071(199809)56:1<33::aid-jmv6>3.0.co;2-o.

DOI:10.1002/(sici)1096-9071(199809)56:1<33::aid-jmv6>3.0.co;2-o
PMID:9700630
Abstract

The putative interferon sensitivity determining region (ISDR) in the NS5a region of the hepatitis C virus (HCV) was analyzed in 13 interferon alpha (IFN-alpha) treated patients representing genotypes 1a, 1b, and 2b. These patients had previously been followed longitudinally during treatment with respect to viral load and to virus heterogeneity using the hypervariable region 1 (HVR1) sequence as a marker. In the present study, the NS5a region was analyzed for nonresponders and sustained responders using direct DNA sequencing. While the previous results of analyzing viral composition and load showed evidence of selection, no corresponding selection of specific NS5a ISDR sequences was observed in the nonresponders, and identical ISDR sequences were observed among both sustained responders and nonresponders. Thus, we cannot verify a correlation between ISDR sequence and the observed selection of IFN-alpha-resistant quasispecies demonstrated as a restriction of HVR1 heterogeneity. This indicates that the potential for using ISDR as a diagnostic or prognostic marker during IFN-alpha treatment is limited.

摘要

相似文献

1
Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatment.
J Med Virol. 1998 Sep;56(1):33-8. doi: 10.1002/(sici)1096-9071(199809)56:1<33::aid-jmv6>3.0.co;2-o.
2
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.丙型肝炎病毒准种在高变区1及假定的干扰素敏感性决定区在干扰素治疗和自然感染期间的演变
J Virol. 1998 May;72(5):4288-96. doi: 10.1128/JVI.72.5.4288-4296.1998.
3
Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-alpha preparations.丙型肝炎病毒E2和NS5A区域在两种α干扰素制剂序贯治疗期间的变异性
J Med Virol. 2003 May;70(1):62-73. doi: 10.1002/jmv.10351.
4
Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.在诱导和联合抗病毒治疗期间对全长丙型肝炎病毒NS5A准种进行前瞻性特征分析。
J Virol. 2000 Oct;74(19):9028-38. doi: 10.1128/jvi.74.19.9028-9038.2000.
5
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?丙型肝炎病毒NS5A基因异质性的研究是否是预测HCV-1b型慢性肝炎患者对干扰素治疗长期反应的一种工具?
J Viral Hepat. 2002 Sep;9(5):360-9. doi: 10.1046/j.1365-2893.2002.00379.x.
6
The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.丙型肝炎病毒1b基因型的非结构5A蛋白不包含干扰素敏感性决定区。
J Infect Dis. 2007 Feb 1;195(3):432-41. doi: 10.1086/510316. Epub 2006 Dec 18.
7
Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy.丙型肝炎病毒 NS5A 和核心蛋白的序列异质性与聚乙二醇干扰素/利巴韦林联合治疗的病毒学应答。
Microbiol Immunol. 2011 Jun;55(6):418-26. doi: 10.1111/j.1348-0421.2011.00331.x.
8
Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses.丙型肝炎病毒1型E2-PePHD、NS5A-PKRBD、NS5A-ISDR和NS5A-V3的突变及其与聚乙二醇干扰素-利巴韦林治疗反应的关系。
J Virol. 2008 Jul;82(13):6644-53. doi: 10.1128/JVI.02231-07. Epub 2008 Apr 30.
9
[Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin].[在使用或不使用利巴韦林进行干扰素治疗前对丙型肝炎病毒NS5A区域的ISDR和V3结构域进行突变分析]
Pathol Biol (Paris). 2004 Nov;52(9):505-10. doi: 10.1016/j.patbio.2004.07.011.
10
Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon.丙型肝炎病毒2a和2b基因型非结构区5A中的氨基酸替换及其与病毒载量和干扰素反应的关系。
Am J Gastroenterol. 2002 Apr;97(4):988-98. doi: 10.1111/j.1572-0241.2002.05619.x.

引用本文的文献

1
Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection.核心突变、IL28B 多态性与聚乙二醇干扰素/利巴韦林治疗瑞典丙型肝炎病毒 1 型感染患者的应答。
BMC Infect Dis. 2011 May 12;11:124. doi: 10.1186/1471-2334-11-124.
2
Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C.影响聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎疗效的病毒因素
J Gastroenterol. 2009;44(10):1009-15. doi: 10.1007/s00535-009-0126-7.
3
Hepatitis C virus diversity and evolution in the full open-reading frame during antiviral therapy.
抗病毒治疗期间丙型肝炎病毒全开放阅读框的多样性与进化
PLoS One. 2008 May 7;3(5):e2123. doi: 10.1371/journal.pone.0002123.
4
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C.慢性丙型肝炎患者干扰素与利巴韦林联合治疗的预测因素
World J Gastroenterol. 2007 Dec 14;13(46):6236-42. doi: 10.3748/wjg.v13.i46.6236.
5
Drug resistance in antiviral treatment for infections with hepatitis B and C viruses.乙型和丙型肝炎病毒感染抗病毒治疗中的耐药性
J Gastroenterol. 2007 May;42(5):329-35. doi: 10.1007/s00535-007-2034-z. Epub 2007 May 25.
6
Viral determinants of resistance to treatment in patients with hepatitis C.丙型肝炎患者治疗耐药性的病毒决定因素。
Clin Microbiol Rev. 2007 Jan;20(1):23-38. doi: 10.1128/CMR.00010-06.
7
Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.丙型肝炎病毒基因组RNA的内部核糖体进入位点对蛋白激酶PKR的抑制作用。
RNA. 2003 Jul;9(7):858-70. doi: 10.1261/rna.5330503.
8
Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection.分析ISDR、PKR结合域和V3区的序列构型,以预测慢性丙型肝炎感染患者对干扰素-α和利巴韦林诱导治疗的反应。
Dig Dis Sci. 2002 Jun;47(6):1195-205. doi: 10.1023/a:1015349924116.
9
Clinical significance of hepatitis C virus genotypes.丙型肝炎病毒基因型的临床意义。
Clin Microbiol Rev. 2000 Apr;13(2):223-35. doi: 10.1128/CMR.13.2.223.